July 28, 2025

Abbott Laboratories (ABT) Stock Analysis: Healthcare Giant Poised for 12.6% Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector with a market capitalization of $220.16 billion, is capturing the attention of investors with its robust portfolio and promising stock..

Amgen Inc. (AMGN) Stock Analysis: Navigating a 2.25% Potential Upside in the Healthcare Sector

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to captivate investor interest with its robust portfolio of human therapeutics and a market capitalization of $164.85 billion. With..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a 7.57% Potential Upside Amid Innovations in Biotechnology

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to treating cystic fibrosis (CF) and other serious diseases...

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 12.43% Upside Potential in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the medical instruments and supplies industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s resilience. With..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Navigating Healthcare Innovation with a 6.28% Upside

IQVIA Holdings, Inc. (NYSE: IQV) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a staggering market capitalization of $33.86 billion, this..

GSK plc (GSK) Investor Outlook: Exploring a 8.89% Upside Potential

GSK plc (NYSE: GSK), a stalwart in the global healthcare sector, continues to capture investor interest with its robust portfolio and a potential upside of 8.89%. With a market capitalization..

argenx SE (ARGX) Stock Analysis: Exploring a 28.49% Potential Upside with Strong Buy Ratings

argenx SE (ARGX), a commercial-stage biopharmaceutical company headquartered in Amsterdam, Netherlands, is generating significant buzz in the biotechnology sector. With a market capitalization of $36.23 billion, argenx stands as a..

Cencora, Inc. (COR) Stock Analysis: A 13.33% Upside Potential with Robust Growth in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a titan in the medical distribution sector, presents a compelling case for investors seeking exposure to the healthcare industry. With a market capitalization of $56.28 billion,..

Medtronic plc (MDT) Stock Analysis: Evaluating Growth Potential in the Medical Devices Sector

Medtronic plc (NYSE: MDT), a prominent player in the medical devices industry, offers an intriguing investment opportunity for those eyeing the healthcare sector. As a leader in device-based medical therapies,..

Gilead Sciences, Inc. (GILD) Stock Analysis: Insight into Its Investment Potential and Growth Prospects

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products. As the company stands at a..

Stryker Corporation (SYK) Stock Analysis: Exploring Its Robust Growth and 5.83% Upside Potential

In the ever-evolving landscape of healthcare, Stryker Corporation (NASDAQ: SYK) stands out as a formidable player in the medical devices industry. With a market capitalization of $154.22 billion, Stryker has..

Novo Nordisk (NVO) Stock Analysis: Examining a 19.79% Potential Upside for Investors

Novo Nordisk A/S (NVO), a titan in the healthcare sector, is not just a staple in the field of diabetes and obesity care but also a stock that has captured..

Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Giant’s 20% Upside Potential

Merck & Company, Inc. (NYSE: MRK), a leading player in the healthcare sector, presents an intriguing opportunity for investors with a potential upside of 20.15%. As a stalwart in the..

Eli Lilly & Company (LLY) Stock Analysis: A $729 Billion Healthcare Giant with 18.36% Potential Upside

Investors looking at the healthcare sector often find themselves drawn to Eli Lilly and Company (NYSE: LLY), a major player in the pharmaceutical industry. With a staggering market capitalization of..

Valeura Energy enters Gulf of Thailand farm‑in with PTTEP

Valeura Energy Inc has signed a Farm‑in Agreement with PTTEP to earn a 40 % interest in offshore Blocks G1/65 and G3/65 in the Gulf of Thailand, expanding its acreage..

Ruffer Investment Company delivers 7.9 % annualised return to 30 June 2025

Ruffer Investment Company Limited has released its Investment Manager’s Year End Review for the year to 30 June 2025, reporting a long‑term annualised return of 7.9 % since launch, after..

Computacenter Plc H1 2025 Trading Outlook

Computacenter plc delivered strong revenue growth in the half year to 30 June 2025, driven by its high‑volume Technology Sourcing business and excellent North America and UK performances, offset by..

FirstGroup plc Acquires Tetley’s Motor Services

FirstGroup plc has acquired Leeds‑based Tetley’s Motor Services Limited, adding 55 coaches and buses and a robust portfolio of school, university, workplace shuttle and private‑hire contracts across the West Yorkshire..

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD,..

Real Estate Credit Investments Investor Day, 8 September 2025

The event will cover an overview of Cheyne Real Estate, UK and European real estate lending challenges and opportunities, RECI’s current portfolio and outlook, and portfolio case studies...
Search

Funds

July 28, 2025

Valeura Energy enters Gulf of Thailand farm‑in with PTTEP

Valeura Energy Inc has signed a Farm‑in Agreement with PTTEP to earn a 40 % interest in offshore Blocks G1/65 and G3/65 in the Gulf of Thailand, expanding its acreage from 2 623 km² to 22 757 km² and adding 15 oil and gas discoveries from 27 wells...

Ruffer Investment Company delivers 7.9 % annualised return to 30 June 2025

Ruffer Investment Company Limited has released its Investment Manager’s Year End Review for the year to 30 June 2025, reporting a long‑term annualised return of 7.9 % since launch, after all fees and charges...

Computacenter Plc H1 2025 Trading Outlook

Computacenter plc delivered strong revenue growth in the half year to 30 June 2025, driven by its high‑volume Technology Sourcing business and excellent North America and UK performances, offset by softer trading in Germany and France and a c.£2 million currency headwind...

FirstGroup plc Acquires Tetley’s Motor Services

FirstGroup plc has acquired Leeds‑based Tetley’s Motor Services Limited, adding 55 coaches and buses and a robust portfolio of school, university, workplace shuttle and private‑hire contracts across the West Yorkshire Combined Authority Area...

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence (ex‑China) for HRS‑9821, a potential best‑in‑class PDE3/4 inhibitor for COPD, for $500 million in upfront fees and up to $12 billion in milestone payments...

Real Estate Credit Investments Investor Day, 8 September 2025

The event will cover an overview of Cheyne Real Estate, UK and European real estate lending challenges and opportunities, RECI’s current portfolio and outlook, and portfolio case studies...
Search

Funds

July 28, 2025

FTSE 100

Funds